Boyd, GB
Alan Christopher Boyd, Edinburgh GB
Patent application number | Description | Published |
---|---|---|
20140242690 | CYSTIC FIBROSIS TREATMENT - The present invention relates to medicaments for the treatment of cystic fibrosis. Also provided are methods of preparing such medicaments so that they can be used in a treatment regime for cystic fibrosis. The present invention also provides a kit of parts including the medicament of the invention, as well as treatment regimes for cystic fibrosis. | 08-28-2014 |
Alistair Boyd, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20120323010 | PROCESSES FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF - The present invention relates to compounds and processes for preparing compounds of Formula (I), | 12-20-2012 |
20130203995 | Process for Making a Metabotropic Glutamate Receptor Positive Allosteric Modulator - 874 - Processes for making 7-methyl-5-(3piperazin-1-ylmethyl-[1,2,4]oxadiazol-5-yl)-2-(4-trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one | 08-08-2013 |
Alistair Boyd, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20140163230 | PROCESSES FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF - The present invention relates to compounds and processes for preparing compounds of Formula (I), | 06-12-2014 |
20150112070 | PROCESSES FOR PREPARING HETEROCYCLIC COMPOUNDS INCLUDING TRANS-7-OXO-6-(SULPHOOXY)-1,6-DIAZABICYCLO[3,2,1]OCTANE-2-CARBOXAMIDE AND SALTS THEREOF - The present invention relates to compounds and processes for preparing compounds of Formula (I), | 04-23-2015 |
Donald Bruce Boyd, Lymington GB
Patent application number | Description | Published |
---|---|---|
20080272810 | FILTERLESS DIGITAL FREQUENCY LOCKED LOOP - A frequency and/or phase locked loop architecture that eliminates the loop filter generally required in conventional phase locked loops, and which may be implemented in digital logic, for example, as a field programmable gate array. In one example, a frequency/phase locked loop includes both a frequency comparison component and a phase comparison component to allow locking of an output clock signal to both the frequency and phase of a reference signal. | 11-06-2008 |
Edward Boyd, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20100120840 | Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents - Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer. | 05-13-2010 |
Edward Boyd, Tymawr GB
Patent application number | Description | Published |
---|---|---|
20090221599 | PHTHALAZINONE PYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS - Objects of the present invention are the compounds of formula I | 09-03-2009 |
Emma Boyd, Crumlin GB
Patent application number | Description | Published |
---|---|---|
20140141075 | 5-AMINOSALICYLIC ACID CAPSULE FORMULATION - A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed. | 05-22-2014 |
20140370083 | 5-AMINOSALICYLIC ACID CAPSULE FORMULATION - A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed. | 12-18-2014 |
Euan James Boyd, Edinburgh GB
Patent application number | Description | Published |
---|---|---|
20140084396 | MEMS DEVICE AND PROCESS - A MEMS capacitive transducer with increased robustness and resilience to acoustic shock. The transducer structure includes a flexible membrane supported between a first volume and a second volume, and at least one variable vent structure in communication with at least one of the first and second volumes. The variable vent structure includes at least one moveable portion which is moveable in response to a pressure differential across the moveable portion so as to vary the size of a flow path through the vent structure. The variable vent may be formed through the membrane and the moveable portion may be a part of the membrane, defined by one or more channels, that is deflectable away from the surface of the membrane. The variable vent is preferably closed in the normal range of pressure differentials but opens at high pressure differentials to provide more rapid equalisation of the air volumes above and below the membrane. | 03-27-2014 |
20140161290 | MEMS DEVICE AND PROCESS - A MEMS capacitive transducer with increased robustness and resilience to acoustic shock. The transducer structure includes a flexible membrane supported between a first volume and a second volume, and at least one variable vent structure in communication with at least one of the first and second volumes. The variable vent structure includes at least one moveable portion which is moveable in response to a pressure differential across the moveable portion so as to vary the size of a flow path through the vent structure. The variable vent may be formed through the membrane and the moveable portion may be a part of the membrane, defined by one or more channels, that is deflectable away from the surface of the membrane. The variable vent is preferably closed in the normal range of pressure differentials but opens at high pressure differentials to provide more rapid equalisation of the air volumes above and below the membrane. | 06-12-2014 |
Ewan Campbell Boyd, Grangemouth GB
Patent application number | Description | Published |
---|---|---|
20080214587 | Processes For the Preparation of Azoxystrobin Using Dabco as a Catalyst and Novel Intermediates Used in the Processes - The present invention relates, inter alia, to a process for preparing a compound of formula (I): which comprises either (a) reacting a compound of formula (II): with 2-cyanophenyl, or a salt thereof, in the presence of between 0.1 and 2 mol % of 1,4-diazabicyclo[2.2.2]octane, or (b) reacting a compound of the formula (III): with a compound of the formula (IV): in the presence of between 0.1 and 2 mol % of 1,4-diazabicyclo[2.2.2]octane; where W is the methyl (E)-2-(3-methoxy)acrylate group C(CO | 09-04-2008 |
Ewan Campbell Boyd, Stirlingshire GB
Patent application number | Description | Published |
---|---|---|
20100036124 | PREPARATION OF AZOXYSTROBIN - The present invention relates, inter alia, to a process for preparing a compound of formula (I): using, as a catalyst 1,4-diazabicyclo[2.2.2]octane. | 02-11-2010 |
20100063275 | PROCESS FOR PREPARING 6-PHENOXYPYRIMIDIN-4-OL DERIVATIVES IN THE PRESENCE OF A QUINUCLIDINE OR A N-METHYL PYRROLIDINE DERIVATIVES - The present invention relates, inter alia, to a process for preparing a compound of formula (I): using a quinuclidine-based catalyst or an optionally 3-substituted N-methyl pryrrolidine-based catalyst. | 03-11-2010 |
Graham Peter Boyd, Chester GB
Patent application number | Description | Published |
---|---|---|
20090222060 | SELF CONTAINED DEVICE WITH TREATMENT CYCLE FOR ELECTROSTIMULATION - An electro-stimulation device for the stimulation of the musculature of the pelvic floor complex e.g. for the treatment of anterior and posterior pelvic floor muscle dysfunction is fully self-contained. The device requires no external power sources or control and may be inserted into the vagina or anus through the use of an applicator. The device uses a pre-programmed treatment cycle of stimulating pulses. The cycle comprises either a waveform with an initial phase where the current of the device is ramped from an initial level to a higher level, a second phase where the current is ramped from the higher level from the first phase to a second higher level and a third phase where the current is maintained at the second higher level, or a waveform comprising two or more components each component being a train of regularly spaced pulses or a combination of these two waveforms. | 09-03-2009 |
20140200646 | COMPRESSIBLE DEVICE - An electro-stimulation device for the treatment of anterior and posterior pelvic floor muscle dysfunction is reversibly compressible and is fully self-contained. The device requires no external power sources or control and may be inserted into the vagina or anus through the use of an applicator. In the compressed state the device may be of tampon proportions and after use may easily be removed. The device utilizes a compressible electrode component. | 07-17-2014 |
20150148881 | COMPRESSIBLE ELECTRODES - A compressible electrode for the stimulation of the musculature of the pelvic floor complex e.g. for the treatment of anterior and posterior pelvic floor muscle dysfunction, is reversibly compressible and has electro-conductive elements. The compressible electrode may be used with all the usual control units and treatment regimes for the electro-stimulation of the musculature and nerves of the vagina and/or anus. The compressible electrode may be inserted into the vagina or anus through the use of an applicator. In the compressed state the compressible electrode may be of tampon proportions and after use may easily be removed. | 05-28-2015 |
Ivan Boyd, Ipswich GB
Patent application number | Description | Published |
---|---|---|
20090136012 | TELECOMMUNICATIONS CALLS - A user accesses a destination such as a call centre | 05-28-2009 |
Ivan Boyd, Ipswich Suffolk GB
Patent application number | Description | Published |
---|---|---|
20110026934 | TRANSMISSION OF BROADBAND SIGNALS - The invention is concerned with the transmission of broadband signals onto to a telephony connection having constraint profile limiting the maximum allowed power as a function of frequency. As a result, broadband signals can be delivered using low power equipment to a telephony line whilst respecting the constraint profile associated with that line. | 02-03-2011 |
Jamie Boyd, Symington GB
Patent application number | Description | Published |
---|---|---|
20100133629 | INTEGRATED SENSOR INCLUDING SENSING AND PROCESSING DIE MOUNTED ON OPPOSITE SIDES OF PACKAGE SUBSTRATE - An integrated circuit (IC) device includes a lead frame having a first and a second opposing surface and a plurality of lead fingers. A first die including a signal processor is mounted on the first surface of the lead frame while a second die is mounted on the second surface of the lead frame. The second die includes at least one sensor that senses at least one non-electrical parameter and has at least one sensor output that provides a sensing signal for the parameter. The sensor output is coupled to the signal processor for processing the sensing signal. | 06-03-2010 |
20120201269 | THERMALLY ISOLATED TEMPERATURE SENSOR - A temperature sensor includes a polymer body for mounting the sensor to a mounting surface and positioning a temperature sensing element within a target fluid. The temperature sensing element may be positioned at the distal end of the polymer body and may be sealed from the fluid by a metal cap filled with a thermally conductive material. In this manner, the polymer body may thermally insulate the temperature sensing element and lead conductors within the polymer body from the mounting surface. The polymer body may also include a connector on the proximal end to facilitate an electrical connection with the temperature sensing element, a flange to install the sensor against the mounting surface, and a fixation surface configured to mate with the mounting surface. In some examples, the polymer body may be constructed in two stages to facilitate different configurations of the connector, flange, and/or fixation surface. | 08-09-2012 |
Joe William Boyd, London GB
Patent application number | Description | Published |
---|---|---|
20130252951 | 7-HYDROXY-PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AND THEIR USE AS CCR2 RECEPTOR ANTAGONISTS - The compounds of formula (I) are antagonists of the CCR2 receptor Wherein R | 09-26-2013 |
20130324556 | Protease Activated Receptor 2 (PAR2) Antagonists - A compound of formula (I) or a pharmaceutically acceptable salt, solvate, or hydrate thereof | 12-05-2013 |
Joseph W. Boyd, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20110059969 | PIPERAZINES AS ANTI-OBESITY AGENTS - The present invention relates to new compounds of formula (I), to pharmaceutical compositions comprising these compounds, to processes for their preparation, and to the use of these compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias. | 03-10-2011 |
Joseph W. Boyd, Cambridgeshire GB
Patent application number | Description | Published |
---|---|---|
20090176798 | New compounds III - The present application relates to new compounds of formula (I), | 07-09-2009 |
20090181967 | New compounds I - The present application relates to new compounds of formula (I), | 07-16-2009 |
20090281087 | Compounds II - The present application relates to new compounds of formula (I), | 11-12-2009 |
20110046135 | NEW COMPOUNDS I - The present application relates to new compounds of formula (I), | 02-24-2011 |
Judith Boyd, Henfield GB
Patent application number | Description | Published |
---|---|---|
20100317660 | Mediators of hedgehog signaling pathways, compositions and uses related thereto - The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist of formula (I) in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity. | 12-16-2010 |
20120283258 | MEDIATORS OF HEDGEHOG SIGNALING PATHWAYS, COMPOSITIONS AND USES RELATED HERETO - The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist of formula (I) in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity. | 11-08-2012 |
Judith Boyd, West Sussex GB
Patent application number | Description | Published |
---|---|---|
20090012082 | Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto - The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity. | 01-08-2009 |
Lewis J. Boyd, Bath GB
Patent application number | Description | Published |
---|---|---|
20150100253 | AIRCRAFT FLUID GAUGING TECHNIQUES USING PRESSURE MEASUREMENTS AND OPTICAL SENSORS - A fluid level measurement system includes a first pressure sensor disposed inside a fluid tank at a first elevation relative to a height axis of the fluid tank, and a second pressure sensor disposed inside the fluid tank at a second elevation relative to the height axis of the fluid tank, the second elevation different from the first elevation. The first pressure sensor and the second pressure sensor are configured to provide a signal indicative of a sensed pressure, and fluid height is calculated from the difference in sensed pressure between the first and second pressure sensors relative to the sensed pressure of either the first or the second pressure sensor. | 04-09-2015 |
Malcolm Boyd, Wellesbourne GB
Patent application number | Description | Published |
---|---|---|
20120289929 | Drive Mechanisms Suitable for Use in Drug Delivery Devices - The present invention relates to drive mechanisms suitable for use in drug delivery devices, in particular pen-type injectors, wherein a number of pre-set doses of medicinal product can be administered. In particular, the present invention relates to such drug delivery devices where a user may activate the drug delivery device. | 11-15-2012 |
Malcolm Boyd, Wellsbourne GB
Patent application number | Description | Published |
---|---|---|
20120330228 | DEVICE AND METHOD FOR DELIVERY OF TWO OR MORE DRUG AGENTS - A computerized electro-mechanical drug delivery device configured to deliver at least one dose of two or more medicaments. The device comprises a control unit. An electro-mechanical drive unit is operably coupled to the control unit and a primary reservoir for a first medicament and a secondary reservoir for a fluid agent, e.g. a second medicament. An operator interface is in communication with the control unit. A single dispense assembly is configured for fluid communication with the primary and the secondary reservoir. Activation of the operator panel sets a first dose from the primary reservoir and based on the first dose and a therapeutic dose profile, the control unit is configured to determine a dose or range of the fluid agent. Alternatively, the control unit determines or calculates a dose or range of a third medicament. Further, a dispense interface for use with a drug delivery device is disclosed. | 12-27-2012 |
Malcolm Boyd, Leamington GB
Patent application number | Description | Published |
---|---|---|
20100137792 | MEDICATION DELIVERY DEVICE AND METHOD FOR OPERATING A MEDICATION DELIVERY DEVICE - A medication delivery device ( | 06-03-2010 |
Malcolm Boyd, Leamington Spa GB
Patent application number | Description | Published |
---|---|---|
20150094687 | Dosing and Drive Mechanism for Drug Delivery Device - The present invention relates to drive mechanisms suitable for use in drug delivery devices, in particular pen-type injectors, wherein a number of pre-set doses of medicinal product can be administered. In particular, the present invention relates to such drug delivery devices where a user may activate the drug delivery device. | 04-02-2015 |
Malcolm Boyd, Warwickshire GB
Patent application number | Description | Published |
---|---|---|
20110306947 | MEDICATION DELIVERY DEVICE AND METHOD FOR OPERATING A MEDICATION DELIVERY DEVICE - A medication delivery device comprises a housing having a proximal end (P) and a distal end (D), a cartridge for holding a medication (M), the cartridge having an outlet, a moveable piston being retained within the cartridge, a drive member moveable in a proximal direction with respect to the housing for setting a dose of medication (M) to be delivered and in the distal direction with respect to the housing for delivering the dose and a piston rod adapted to drive the piston in a distal direction with respect to the cartridge for delivering the dose. The drive member is releasably coupled to the piston rod. The medication delivery device further comprises a resilient member which is arranged to move the drive member in the proximal direction with respect to the housing after dose delivery, thereby reducing pressure of the piston rod on the piston. | 12-15-2011 |
20120037530 | Drug Delivery Device - The present invention relates to a drug delivery ( | 02-16-2012 |
20120089098 | Drug Delivery Device - The present invention relates to a drug delivery ( | 04-12-2012 |
20120172816 | Drive Mechanisms Suitable for Use in Drug Delivery Devices - The present invention relates to drive mechanisms suitable for use in drug delivery devices, in particular pen-type injectors, wherein a number of pre-set doses of medicinal product can be administered. In particular, the present invention relates to such drug delivery devices where a user may activate the drug delivery device. | 07-05-2012 |
Malcolm Richard Boyd, Epsom Surrey GB
Patent application number | Description | Published |
---|---|---|
20080287389 | Nucleoside analogs in combination therapy of herpes simplex infections - A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or peniclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections. | 11-20-2008 |
20100323952 | Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections - A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or peniclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections. | 12-23-2010 |
Malcolm Stanley Boyd, Warwick GB
Patent application number | Description | Published |
---|---|---|
20150151139 | Controlling access to radiotherapy systems - A system for identifying users and controlling access to a radiotherapy apparatus, comprising: a portable identification device, comprising a memory for storing identification information corresponding to a user of the device and an antenna; and a control mechanism for a radiotherapy apparatus, comprising: a wireless transceiver for communicating with the portable identification device and identifying the user of the portable identification device; and a display for displaying a user interface and receiving inputs for controlling the radiotherapy apparatus on the basis of the identified user when the portable identification device is placed on the display. | 06-04-2015 |
Malcolm Stanley Boyd, Warwickshire Warks GB
Patent application number | Description | Published |
---|---|---|
20120029440 | APPARATUS FOR HOLDING A COVER OF A NEEDLE UNIT AND METHOD - An apparatus comprises a recess configured to hold an outer cover of a needle packaging for providing a needle unit. The outer cover is suitable to cover at least a part of a needle unit for a medication delivery device. | 02-02-2012 |
Malcolm Stanley Boyd, Warwickshire GB
Patent application number | Description | Published |
---|---|---|
20120029442 | DRUG DELIVERY DEVICE - The present invention relates to drug delivery devices. The drug delivery device according to the invention includes a housing with a needle holder suitable for attaching a needle unit to the housing at the distal end, and a cap being capable of covering the distal end of the drug delivery device and comprising a retaining member capable of securing the cap by engaging with the housing, the retaining member is prevented from engaging with the housing with the needle unit being attached to the needle holder. Furthermore, using a cap for covering the distal end of the drug delivery device is disclosed. | 02-02-2012 |
20120123346 | MEDICATED MODULE WITH NEEDLE GUARD - A medicated module comprising a connecting body configured for attachment to a drug delivery device. A first needle is fixed within the connecting body and an outer body operatively coupled to the connecting body. A needle guard operatively coupled to the outer body and a biasing member positioned between the outer body and needle guard. A second needle fixed within the outer body and a recess within the connecting body defines a reservoir. The reservoir contains at least one dose of a medicament and is configured for fluid communication with the first and second needle. | 05-17-2012 |
20120123347 | Medication Delivery Device - A medication delivery device comprises a housing ( | 05-17-2012 |
20120125951 | Delivery of Two or More Medicaments Through a Single Dose Selection and Single Dispense Interface - A injection system for co-delivery of two medicaments ( | 05-24-2012 |
20120130316 | Drug Delivery Device - The present invention relates to a drug delivery comprising a housing ( | 05-24-2012 |
20120130346 | Medicated Module for a Drug Delivery Device - A medicated module ( | 05-24-2012 |
20120136316 | Medicated Module With User Selection - A medicated module ( | 05-31-2012 |
20120136334 | Delivery of Two or More Medicaments Through a Single Dose Selection and Dispense Interface - An injection system for co-delivery of two medicaments ( | 05-31-2012 |
20130231613 | DRUG DELIVERY DEVICE HAVING A TRIGGER - A drug delivery device having a trigger biasing member that provides dispense assistance. The drug delivery device includes a variable dose setting mechanism that is operably coupled to a primary reservoir holding a first medicament. The drug delivery device also includes a fixed dose setting mechanism that is operably coupled to a secondary reservoir holding a second medicament. The fixed dose setting mechanism comprises a trigger biasing member or spring. In addition, the drug delivery device includes a mechanical coupling that operably couples the variable dose setting mechanism and the fixed dose setting mechanism. During dose setting, activation of a single dose setter sets a variable dose of the first medicament. Setting of a minimum dose of the first medicament causes a fixed dose of the second medicament to be automatically set, and, during dispense, the trigger spring at least assists with the dispense of the fixed dose of the second medicament. | 09-05-2013 |
20130237924 | DRUG DELIVERY DEVICE HAVING LINKED DOSE DIAL COMPONENTS - A drug delivery device for co-delivery of two medicaments. The drug delivery device has a dose setter, a first dose dial component, a second dose dial component, and a collar. The first dose dial component is configured to select a first dose of a first medicament, and the first dose dial component is operably connected to the dose setter. The second dose dial component is configured to select a second dose of a second medicament. In addition, the first dose dial component and the second dose dial component are connected to the collar. The collar is configured to be moved in a proximal direction by actuation of the dose setter. Further, when the collar is moved in a proximal direction, the first dose dial component and the second dose dial component are configured to move proximally to set a dose “A” for the first medicament with the first dose dial component and set a dose “B” for the second medicament with the second dose dial component. | 09-12-2013 |
20130237932 | Medicated Module with Automatic Reservoir Engagement - A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle. The medicated module does not require the user to manually engage a reservoir containing the secondary medicament. Instead, a biasing member automatically activates the reservoir when the needle guard is retracted. The needle guard prevents accidental needle sticks before and after an injection, and locks after dose delivery. | 09-12-2013 |
20130237935 | Ophthalmic Drug Delivery Device with a Medicated Module - An ophthalmic drug delivery device containing a primary medicament reservoir and a replaceable medicated module containing a second medicament where the device has a selector to allow dispense of primary medicament or a combination of the primary and secondary medicaments such that a single activation of the ophthalmic drug delivery will deliver both medicaments to the user. | 09-12-2013 |
20130245561 | Medicated Module for Use with Auto-Injector Delivery Device - A drug delivery system to deliver two or more medicaments operable through a auto-injector drug delivery device and a single dispense interface. The device comprises a housing defining a primary reservoir containing a first medicament. A dosing mechanism operably connected to the primary reservoir. A single dispense interface is configured for fluid communication with the primary reservoir and a secondary reservoir of medicament containing at least one drug agent configured for fluid communication to the single dispense interface. A single activation of the dosing mechanism causes medicament from the primary reservoir and a non-user settable dose of the second medicament to be expelled through the single dispense interface. | 09-19-2013 |
20130245562 | Automatic Delivery Device with Triggering Mechanism - The present patent application relates to delivery devices, methods, and systems of delivering at least one medicament from a reservoir using an automatic delivery device. Such an automatic delivery device system may comprise a dose injecting mechanism and a dispense interface, such as a needle module. The dose injecting mechanism comprises a triggering mechanism. An activating member, such as a needle guard of the needle module, can be used to initiate the triggering mechanism to enable the device to administer the set dose. The single dispense interface may comprise a medicated module containing at least one dose of a secondary medicament. The dose injecting mechanism may comprise a dose setting mechanism. | 09-19-2013 |
20130245563 | Medicated Module with Automatic Reservoir Engagement - A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle. The medicated module does not require the user to manually engage a reservoir containing the secondary medicament. Instead, a rotating housing automatically activates the reservoir when the needle guard is retracted. The needle guard prevents accidental needle sticks after an injection, and locks after dose delivery. | 09-19-2013 |
20130245565 | DRUG DELIVERY DEVICE HAVING A SPRING ELEMENT - A drug delivery device having a spring element that provides dispense assistance. The drug delivery device includes a variable dose setting mechanism, a fixed dose setting mechanism, and a mechanical coupling having a spring element. The variable dose setting mechanism is operably coupled to a first reservoir holding a first medicament, and the variable dose setting mechanism comprises a dose setter. The fixed dose setting mechanism is operably coupled to a second reservoir holding a second medicament. The mechanical coupling operably couples the variable dose setting mechanism and the fixed dose setting mechanism. Further, the variable dose setting mechanism is configured to set a variable dose of the first medicament upon activation of the dose setter, and the fixed dose setting mechanism is configured to set a fixed dose of the second medicament during variable dose setting. Still further, the spring element is configured to store energy during dose setting and to transfer stored energy to the fixed dose setting mechanism to assist with dispense of the fixed dose. | 09-19-2013 |
20130245579 | MEDICATED MODULE FOR AN OPHTHALMIC DRUG DELIVERY DEVICE - A medicated module containing a second medicament is configured for removable attachment to ophthalmic drug delivery device containing a first medicament such that a single activation of the ophthalmic drug delivery will deliver both medicaments to the user. | 09-19-2013 |
20130245604 | Auto-Injector Device with a Medicated Module - Disclosed herein are various examples of a drug delivery system and corresponding method for delivering three or more medicaments. The system includes two major components: an auto-injector device that contains at least two medicaments and a medicated module that contains at least one medicament. The medicated module interfaces with the auto-injector device such that a combination dose comprising all of the medicaments can be delivered via a single dispense interface of the medicated module. In order to deliver a pre-defined combination dose, a user need only set the dose of one of the medicaments contained in the auto-injector device and need only activate the system once by actuating a dose delivery button on the auto-injector device. | 09-19-2013 |
20130253430 | Multi-Reservoir Pump Patch - A device to co-deliver at least two medicaments is disclosed where a first reservoir containing a primary medicament is connected to a manifold and cannula and where one or more additional reservoirs are placed in fluid communication with the manifold in parallel or inline flow. The additional reservoir(s) can be located within the device or as part of an attachable medicated module that connects to external port located on the device housing. Both medicaments are delivered through a cannula subcutaneously. The device is configured to be user wearable through attachment directly to the skin by an adhesive. | 09-26-2013 |
20130253440 | Drug Delivery Device - A drug delivery device having a dose limiting system. The drug delivery device includes a first dose setting mechanism operably coupled to a primary reservoir holding a first medicament. The first dose setting mechanism includes a first dose setter and is a variable dose setting mechanism. The device further includes a second dose setting mechanism operably coupled to a secondary reservoir holding a second medicament, and the second dose setting mechanism includes a second dose setter. Still further, the device includes a dose limiting system. The dose limiting system operably couples the variable dose setting mechanism and the fixed dose setting mechanism. Further, the dose limiting system is configured to limit a settable amount of a dose of the second medicament a user can set using the second dose setter based on an amount of a variable dose that a user sets using the first dose setter. | 09-26-2013 |
20130253441 | Drug Delivery Device and Method for Sequentially Delivering at Least Two Medicaments - Various examples of a drug delivery device and corresponding method for sequentially delivering at least two medicaments via a single dispense interface are provided. In one example, the device includes a variable dose setting mechanism operably connected to a first cartridge containing a first medicament, a fixed dose setting mechanism operably connected to a second cartridge containing a second medicament, a dose setter for setting a user settable dose of the first medicament and a fixed dose of the second medicament, and a connecting feature for detachably connecting the variable dose setting mechanism to the fixed dose setting mechanism. During setting of the fixed dose of the second medicament, the rotationally driven variable dose setting mechanism and the fixed dose setting mechanism are connected via the connecting feature, however, during setting of the user settable dose of the first medicament, the rotationally driven variable dose setting mechanism and the fixed dose setting mechanism are not connected. | 09-26-2013 |
20130253465 | Dispense Interface Component for a Drug Delivery Device - A dispense interface component for use with a drug delivery device is provided. The dispense interface component may include a main body, a first piercing portion, a second piercing portion, and a biasing element. The main body is configured for connection to the drug delivery device. The first piercing portion is for piercing a first cartridge contained within the drug delivery device, and the first piercing portion is connected to the main body. The second piercing portion is for piercing a second cartridge contained with the drug delivery device, and the second piercing portion is connected to the main body. The at least one biasing element is operably coupled to the main body, wherein the at least one biasing element is configured to, when the load on the at least one biasing element is less than or equal to a threshold load, bias (i) the first piercing portion away from the first cartridge and (ii) the second piercing portion away from the second cartridge. | 09-26-2013 |
20140025015 | Medicated Module with Automatic Reservoir Engagement and Trigger Lock Mechanism - A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle. The medicated module does not require the user to manually engage a reservoir containing the secondary medicament. Instead, a biasing member automatically activates the reservoir when the needle guard is retracted. The needle guard prevents accidental needle sticks before and after an injection, and locks after dose delivery. A biasing member is provided within the medicated module that may be in a first, trigger-locked position within a secondary packaging, and a second, triggerable position when removed from the secondary packaging to prevent accidental triggering of the device prior to removal from its packaging by the user at the point of use. | 01-23-2014 |
20140031759 | MEDICATED MODULE ASSEMBLY WITH AUTOMATIC TRIGGER - A module assembly for use with an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts the module that has an automatic triggering system activated by a dispense interface needle guard. When the module contains a single dose of a secondary medicament, both the primary and secondary medicaments are delivered through a single dispense interface, preferably a hollow needle. The module assembly does not require the user to manually engage a reservoir containing the secondary medicament. Instead, a trigger automatically activates movement of a lower hub when the needle guard is retracted. | 01-30-2014 |
20140031760 | MEDICATED MODULE WITH LOCK RING - A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle. The medicated module is initially in a locked state until attached to a drug delivery where a locking plate is moved to a triggering state. The medicated module does not require the user to manually engage a reservoir containing the secondary medicament. Instead, a biasing member automatically activates the reservoir when the needle guard is retracted when the module is in the triggering state. The needle guard prevents accidental needle sticks before and after an injection, and locks after dose delivery. | 01-30-2014 |
20140058333 | MEDICATED MODULE WITH AUTOMATIC RESERVOIR ENGAGEMENT AND LOCK MECHANISM - A module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle. The module does not require the user to manually engage a reservoir containing the secondary medicament. Instead, a biasing member automatically activates the reservoir when the needle guard is retracted. The needle guard prevents accidental needle sticks before and after an injection, and locks after dose delivery. Restraining features are present on the module to prevent the needle guard from moving relative to the device, in a trigger locked position. | 02-27-2014 |
20140128817 | Medicated Module with User Selection - A medicated module ( | 05-08-2014 |
20140194815 | INFUSION PUMP DRUG DELIVERY SYSTEM FOR DELIVERING AT LEAST TWO MEDICAMENTS - The infusion pump drug delivery system and corresponding method disclosed herein allow for continuous delivery of a first fluid and/or medicament from a reservoir operably connected to a pump and selective delivery of a second fluid and/or medicament from a separate reservoir, where the second fluid and/or medicament may be delivered sequentially or simultaneously with the first fluid and/or medicament at the command of the user. Both fluids and/or medicaments are delivered via a single dispense interface. | 07-10-2014 |
20140249480 | Medicated Module with Automatic Activation Mechanism - Disclosed herein are various examples of a medicated module that can be attached to a drug delivery device such that a user can administer a user settable dose of a first medicament and a fixed dose of a second medicament through a single dispense interface. In one example, the medicated module includes (i) an outer housing having a hub that holds a first needle, (ii) a bypass housing including a reservoir containing a second medicament, (iii) a lower hub including a second needle, (iv) a slidable needle guard including at least one disengagement member, where the needle guard is configured to activate the medicated module by forcing the bypass housing to disengage from the outer housing at a pre-defined amount of proximal displacement of the needle guard; and (v) a biasing member, where the biasing member is configured to place the second needle in fluid communication with the first and second medicaments automatically after activation of the medicated module. | 09-04-2014 |
Malcolm Stanley Boyd, Wellesbourne GB
Patent application number | Description | Published |
---|---|---|
20120220949 | MEDICATED MODULE WITH INTEGRAL FLOW DISTRIBUTION SYSTEM - A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament contained within a capsule having an integral flow distributor/distribution system and where both medicaments are delivered through a single hollow needle. | 08-30-2012 |
20120226238 | MEDICATED MODULE WITH BYPASS AND NEEDLE GUARD - A medicated module attachable to a drug delivery device comprises a connecting body configured for attachment to the drug delivery device. A first needle is fixed within the connecting body and a movable needle hub is operatively coupled to the connecting body. A needle guard is operatively coupled to the connecting body and a biasing member is positioned between the connecting body and needle guard. A second needle is fixed within the needle hub. A first cavity within the connecting body defines a reservoir containing at least one dose of a medicament. The reservoir configured for fluid communication with the first and the second needle. The reservoir comprises a bypass configured to allow medicament from the drug delivery device to bypass the reservoir and exit the second needle. | 09-06-2012 |
20130018310 | Medicated Module with Time Lock - A medicated module ( | 01-17-2013 |
20130018323 | Flexible Reservoir for a Medicated ModuleAANM Boyd; Malcolm StanleyAACI WellesbourneAACO GBAAGP Boyd; Malcolm Stanley Wellesbourne GBAANM Davies; James AlexanderAACI Leamington SpaAACO GBAAGP Davies; James Alexander Leamington Spa GBAANM Wallace; Andrew GordonAACI HighleadonAACO GBAAGP Wallace; Andrew Gordon Highleadon GBAANM Sanders; DavidAACI WarwickAACO GBAAGP Sanders; David Warwick GB - A reservoir ( | 01-17-2013 |
20130090604 | PUSH ROD ACTIVATED MEDICATED MODULE - A medicated module for an injection system to co-deliver at least two medicaments is disclosed. The drug delivery device includes a push rod operably connected to a dose dial button. The medicated module includes a housing having a connector configured for attachment to the drug delivery device, and the housing is configured to receive a portion of the push rod when the medicated module is attached to the drug delivery device. The medicated module further includes a reservoir in the housing comprising a single dose of a medicament and a needle guard operably connected to the housing and configured to move in an axial direction during application to an injection site. Still further, the medicated module includes a sleeve in the housing configured to move axially in the housing and a locking collar in the housing configured to move axially and rotationally in the housing. | 04-11-2013 |
20130197474 | Medicated Module Having a Double Needle Guard - A medicated module ( | 08-01-2013 |
20130231614 | Dedicated Needle Assembly - A dedicated needle assembly ( | 09-05-2013 |
20130261556 | MEDICATED MODULE FOR AN OPHTHALMIC DRUG DELIVERY DEVICE - A drug delivery device having a collar and a linkage component. The drug delivery device includes a variable dose setting mechanism, a fixed dose setting mechanism, a single dose setter, a collar, and a linkage component. The variable dose setting mechanism is operably coupled to a primary reservoir holding a first medicament. The fixed dose setting mechanism is operably coupled to a secondary reservoir holding a second medicament. Further, the single dose setter is operably coupled to the variable dose setting mechanism, and the collar is disposed on the variable dose setting mechanism. Still further, the linkage component is disposed on the fixed dose setting mechanism, wherein the linkage component is capable of engagement with the collar. | 10-03-2013 |
20130267908 | DRUG DELIVERY DEVICE - A drug delivery device having a fixed dose setting mechanism with a biasing element. The drug delivery device includes a first dose setting mechanism, where the first dose setting mechanism is operably coupled to a primary reservoir holding a first medicament. The device also includes a dose setter operably coupled to the first dose setting mechanism. The device further includes second dose setting mechanism, where the second dose setting mechanism is operably coupled to a secondary reservoir holding a second medicament. The second dose setting mechanism is mechanically linked to the first dose setting mechanism, and the second dose setting mechanism includes a biasing element. The dose setter is configured to set a variable dose of the first medicament and automatically set a fixed dose of the second medicament upon activation. In addition, the biasing element is configured to assist with dispense of the second medicament. | 10-10-2013 |
20140094757 | MEDICATED MODULE WITH LOCK FEATURE - A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle. The medicated module is initially in a locked state until attached to a drug delivery where interaction of the cartridge holder with the module bypass housing changes the module to a triggerable state. The medicated module does not require the user to manually engage a reservoir containing the secondary medicament. Instead, a biasing member automatically activates the reservoir when the needle guard is retracted when the module is in the triggerable state. The needle guard prevents accidental needle sticks before and after an injection, and locks after removal from the injection site. | 04-03-2014 |
Malcolm Stanley Boyd, Wellsbourne GB
Patent application number | Description | Published |
---|---|---|
20130041321 | MEDICATED MODULE WITH USER SELECTION - A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle. The medicated module is user selectable so that it will deliver a priming dose of a primary medicament or both the primary and secondary medicaments. The module also contains a needle guard that locks after dose delivery. The needle guard prevents accidental needle sticks before and after an injection. A locking collar rotates during use as an inner protrusion follows three paths of a track located on the outer surface of a body housing. When the inner facing protrusion is in the third path, it encounters a hard stop and a rotational bias that locks the guard from further refraction and thus covers the sharp distal end of the needle. | 02-14-2013 |
20130046246 | NEEDLE ASSEMBLY - Disclosed is a safety needle assembly has a needle guard that prevents accidental needle sticks before and after an injection. A locking collar rotates during use as an inner protrusion follows three paths of a track located on the outer surface of a body housing. When the inner facing protrusion is in the third path, it encounters a hard stop and a rotational bias that locks the guard from further retraction and, thus, covers the sharp distal end of the needle. | 02-21-2013 |
20130079724 | MEDICATED MODULE WITH DUAL SAFETY GUARDS - A medicated module for an injection system to co-deliver at least two medicaments is disclosed, where a drug delivery device containing a primary medicament accepts a medicated module containing a single dose of a second medicament and where both medicaments are delivered through a single hollow needle. The medicated module comprises two housings removably connected to each other, where each housing contains a sterile needle and needle needle guard assembly that locks out after the needle is inserted in an injection site. | 03-28-2013 |
20130110050 | MEDICATED MODULE WITH LOCKABLE NEEDLE GUARD | 05-02-2013 |
20130204186 | MEDICATED MODULE WITH AUTOMATIC RESERVOIR ENGAGEMENT - A medicated module ( | 08-08-2013 |
Malcom Stanley Boyd, Warwickshire GB
Patent application number | Description | Published |
---|---|---|
20130226086 | Medicated Module with Interlock - A medicated module attachable to a drug delivery device comprising a connecting body configured for attachment to the drug delivery device. A first needle held within a first needle hub of the connecting body and a second needle fixed within a second needle hub of the connecting body. A recess within the connecting body defining a reservoir. The reservoir containing at least one dose of a medicament and configured for fluid communication with the first needle. The connecting body further comprises a lockout feature that prevents the medicated module from being reconnected to the drug delivery device after the medicated module has been connected to the drug delivery device a first time. | 08-29-2013 |
Mark Lockyer Boyd, Suffolk GB
Patent application number | Description | Published |
---|---|---|
20130062823 | Workbench - The workbench includes one or more trestle units ( | 03-14-2013 |
Mark Thomas Boyd, Handbridge GB
Patent application number | Description | Published |
---|---|---|
20090017538 | Mammalian MDM2 Binding Proteins and Uses Thereof - Isolated nucleic acid sequences encoding mammalian binding protein and polypeptide sequences for the mammalian MDM2 binding protein are provided. Also provided are vectors containing these nucleic acid sequences, host cells which express these proteins and antibodies targeted to these proteins. In addition, methods and compositions for modulating the G | 01-15-2009 |
20100286362 | Mammalian MDM2 Binding Proteins and Uses Thereof - Isolated nucleic acid sequences encoding mammalian MDM | 11-11-2010 |
Nathan Boyd, Manchester GB
Patent application number | Description | Published |
---|---|---|
20090266154 | IN-BOREHOLE GAS MONITOR APPARATUS AND METHOD - A self-contained in-borehole gas monitor (IGM) apparatus ( | 10-29-2009 |
20100132440 | FLUID MONITORING APPARATUS AND A METHOD OF OPERATING THE SAME - A sampling apparatus for sampling a fluid, the apparatus comprising a sensor and a flow regulator open to allow the continuous flow of fluid through the apparatus past the sensor. | 06-03-2010 |
Peter John James Boyd, Ballyclare GB
Patent application number | Description | Published |
---|---|---|
20150136143 | COMBINATION THERAPY INTRAVAGINAL RINGS - The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of dapivirine in combination with either an antimicrobial compound or a contraceptive to a human. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, methods of preventing unintended pregnancy in a female human, and methods of preparing intravaginal rings. | 05-21-2015 |
Robert Simon Boyd, Abingdon GB
Patent application number | Description | Published |
---|---|---|
20100015152 | Diagnostic and therapeutic methods - The present invention provides the use of a protein found in breast, prostate, pancreatic and colon cancer cell membranes, known as BCMP 7, in the diagnosis, screening, treatment and prophylaxis of breast, prostate, pancreatic and/or colon cancer, as well as compositions comprising BCMP 7, including vaccines and antibodies that are immunospecific for BCMP 7. | 01-21-2010 |
20110150877 | EPHRIN-B RECEPTOR PROTEIN INVOLVED IN CARCINOMA - The present invention provides a polypeptide (CCMP-1) of use in the diagnosis, screening, treatment and prophylaxis of carcinoma. Also provided are compositions comprising the protein, vaccines and antibodies that are immunospecific for the protein. | 06-23-2011 |
Rod Boyd, London GB
Patent application number | Description | Published |
---|---|---|
20110246908 | INTERACTIVE AND SHARED VIEWING EXPERIENCE - A shared environment is provided for electronic media devices such as game consoles which have Internet connectivity for receiving streaming video content. The shared environment is a virtual world which includes the video content as well as avatars which represent a group of users who have agreed to watch the content together, and scene elements which provide a realistic and eye-catching appearance. The users can enter commands to cause their avatars to emote, such as by cheering. The users can also explore the shared environment from different camera angles. A voice and/or video chat channel can also be enabled to allow the users to speak to and see one another. The video content is synchronized among the electronic media devices of the users so that the users' interactions are more meaningful as they can react to the same portion of the video content in real time. | 10-06-2011 |
Rodney Alan Boyd, London GB
Patent application number | Description | Published |
---|---|---|
20090315893 | USER AVATAR AVAILABLE ACROSS COMPUTING APPLICATIONS AND DEVICES - An avatar along with its accessories, emotes, and animations may be system provided and omnipresent. In this manner, the avatar and its accessories, emotes, and animations may be available across multiple environments provided or exposed by multiple avatar computing applications, such as computer games, chats, forums, communities, or instant messaging services. An avatar system may change the avatar and its accessories, emotes, and animations, e.g. pursuant to a request from the user, instructions from an avatar computing application, or updates provided by software associated with a computing device. The avatar and its accessories, emotes, and animations may be changed by a system or computing application associated with a computing device outside of a computer game or computing environment in which the avatar may be rendered or used by the user. | 12-24-2009 |
20100009747 | Programming APIS for an Extensible Avatar System - Disclosed is an application programming interface (API) that provides for an extensible avatar system. In one embodiment an API may allow video game applications to retrieve structures of data which represent an avatar. The game can then take those structures and incorporate the data into its own rendering system. In another embodiment an API may allow a video game application to render an avatar to a render target or texture wherein the video game system performs rendering and animation functions. | 01-14-2010 |
Scott Boyd, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20080207636 | Compounds Effecting Glucokinase - The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R | 08-28-2008 |